Product Pipeline

We have multiple and diverse cancer immunotherapies in our pipeline. These are in clinical and preclinical development directed against a range of cancer targets that have been identified and validated by Immatics’ proprietary XPRESIDENT® technology platform.

 

 

 

Immatics Product Pipeline
We use cookies to ensure that we give you the best experience on our website.